[Experience in the use of T-activin in patients with malignant testicular tumors and patients with kidney cancer].
The paper discusses data on combined T-activin and cytostatic drug treatment of 9 cases of extensive cancer of the kidney and 9 cases of disseminated malignant tumor of the testicle. An immunomodulating effect of T-activin was shown.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000493:Allopurinol / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D013736:Testicular Neoplasms / Q000188:drug therapy*; D013949:Thymus Extracts / Q000627:therapeutic use*; D014747:Vinblastine / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; D001761:Bleomycin; D014747:Vinblastine; D000493:Allopurinol; C036191:T-activin; D002945:Cisplatin; D005472:Fluorouracil
Opyt primeneniia T-aktivina u bol'nykh zlokachestvennymi opukholiami iaichka i bol'nykh rakom pochek.